Concerns over use of hydroxyethyl starch solutions
- PMID: 25385352
- PMCID: PMC4707718
- DOI: 10.1136/bmj.g5981
Concerns over use of hydroxyethyl starch solutions
Abstract
Large trials have shown that hydroxyethyl starch increases the risk of death, kidney injury, and bleeding. However, an EMA review last year permitted continued use in some patients, overturning an earlier decision to withdraw the product completely. Christiane Hartog and colleagues discuss the evidence and call on doctors to avoid using starch formulations
Conflict of interest statement
Competing interests: We have read and understood BMJ policy on declaration of interests and declare that KR is unpaid chairman of the Global Sepsis Alliance, which is sponsored by B Braun and CSL Behring. The opinions expressed in this article do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government.
References
-
- Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39. - PubMed
-
- Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11. - PubMed
-
- Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 2012;367:124-34. - PubMed
-
- HES market sales analysis. www.imshealth.com/portal/site/imshealth upon payment.
-
- Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013;2:CD000567. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous